NEW YORK (TheStreet) -- CHANGE IN RATINGS
Abercrombie & Fitch (ANF) was upgraded at Janney Montgomery to buy from neutral. Twelve-month price target is $49. Company is cutting costs and can exceed low earnings expectations, Janney Montgomery said.
Alliant Techsystems (ATK) was upgraded at Argus to buy from hold. Twelve-month price target is $139. Company is relying more on its consumer business and less on government contracts, Argus said.
Avery Dennison (AVY) was upgraded at Topeka Capital to buy from hold. Twelve-month price target is $59. Domestic checks suggest that fundamentals are improving, Topeka Capital said.
Acuity Brands (AYI) was upgraded at Wedbush to neutral from underperform. Twelve-month price target is $120. Company is realizing higher margins, Wedbush said.
Allegheny Technologies (ATI) was downgraded at Deutsche Bank to hold from buy. Twelve-month price target is $36. Steel price momentum will likely slow, Deutsche Bank said.
Baidu.com (BIDU) was upgraded at Maxim Group to buy from hold. Twelve-month price target is $200. Expect continued growth of China's Internet economy and increasing efforts on new products and markets, Maxim Group said.
BlackRock (BLK) was downgraded at Goldman Sachs to neutral. Valuation call, following the outperformance in 2013, Goldman said.
Con-Way (CNW) was upgraded at Wells Fargo to outperform from market perform. Earnings expectations are more reasonable, given the current valuation, Wells Fargo said.
Fossil (FOSL) was downgraded at Keybanc to underweight from hold. Twelve-month price target is $100. Company should see continued weakness in the domestic wholesale watch market, Keybanc said.
Hartford (HIG) was upgraded at Wells Fargo to outperform from market perform. Visibility is improving, regarding the company's restructuring plans, Wells Fargo said.
Intact Financial (IFC:Toronto) was initiated at UBS with a buy rating. Superior ROE and industry leading market share, UBS said. Twelve-month price target is $80.
Janus (JNS) was upgraded at Goldman Sachs to neutral. Company is seeing better returns and should have less of a performance-fee drag, Goldman said.
Liberty Property Trust (LRY) was upgraded at UBS to buy from neutral. Portfolio repositioning is a fundamental positive and development is driving growth, UBS said. Twelve-month price target is $38.
Las Vegas Sands (LVS) was downgraded at FBR Capital Markets to market perform from outperform. Twelve-month price target is $85. Consensus expectations appear too bullish, FBR Capital Markets said.
Marvell MRVL was initiated with a buy rating at MKM Partners. Twelve-month price target is $19. Company is exposed to China Mobile's LTE handset market.
Maxim (MXIM) was downgraded at Oppenheimer to perform from outperform. Mobile headwinds could weigh on growth in the coming quarters, Oppenheimer said.
Omega Healthcare Investors (OHI) was downgraded at UBS to sell from neutral. Valuation doesn't adequately reflect credit risk of nursing tenants and permanent doc-fix bill could hurt sustainable rate formula, UBS said. Twelve-month price target is $31.
PulteGroup (PHM) was downgraded at J.P. Morgan to underweight. Valuation call, as the company has limited room to expand margins, J.P. Morgan said.
Qlik Tech (QLIK) was upgraded at Jefferies to buy from hold. Valuation call and next product release could help fundamentals, Jefferies said. Twelve-month price target is $35.
Transdigm (TDG) was downgraded at DA Davidson to neutral from buy. Valuation call, DA Davidson said.
Target (TGT) was upgraded at Goldman Sachs to buy. Twelve-month price target is $72. Company is poised for a recovery, following a tough 2013, Goldman said.
Ventas (VTR) was upgraded at UBS to buy from neutral. Valuation call after stock selloff, UBS said. Twelve-month price target is $63.
Washington Federal (WAFD) was upgraded at Sterne Agee to buy from neutral. Company is leveraged to a steeper yield curve and acquisitions should augment growth, Sterne Agee said.
Wisdomtree (WETF) was downgraded at Goldman Sachs to neutral. Valuation call, Goldman Sachs said.
Stock Comments / EPS ChangesAbercrombie & Fitch 12-month price target, EPS estimates were increased at Jefferies. Holiday surprise on the upside, which prompted management to raise guidance. Still may need to improve real fundamentals, Jefferies said. Twelve-month price target is $34. Hold rating.
J.C. Penney (JCP) numbers were reduced at Goldman Sachs. Shares are now seen reaching $7 over 12 months. Estimates were also cut, given general weakness in retail activity, Goldman said. Neutral rating.